FACT-CHECK
Why FormFactor Stock Fell 34% Despite a $300M Teradyne Deal
FormFactor and AMSC are 34% and 25% off their highs, but no filing shows a company-specific problem; the cause is press-only or unconfirmed.
Every time FormFactor (FORM) moved sharply, checked against filings and numbers. 3 article(s), newest first.
FormFactor and AMSC are 34% and 25% off their highs, but no filing shows a company-specific problem; the cause is press-only or unconfirmed.
A look at cryogenic amplifiers, wiring and dilution refrigerators in quantum computing, and where QSI, AmpliTech Group, QTREX Quantum and FormFactor stand.
United Therapeutics (patent ruling, +12.55%), Rogers (investor-day targets, +10.73%) and FormFactor (buy rating, +9.59%) rose on Sept. 30 for different reasons of different strength.